Microplastic pollution is a significant global environmental issue, and impacts span from individual organisms to the entire ecosystems. This study investigated the properties of microplastics in amphibian larvae, shedding light on their environmental interactions and potential ecological consequences. We examined microplastics extracted from amphibian larvae of 10 taxa, sampled from sites experiencing different levels of human impact. Our findings revealed a predominance of blue microplastics and fibres, each comprising 53% of the total microplastics in amphibian larvae. Microplastic fibres were also notably longer than other morphological types of microplastics. Furthermore, we observed variations in the surface area of microplastics among different amphibian families. An interesting observation from our research is the apparent positive relationship between the size of amphibian larvae and the length of granular and flake-shaped microplastics. Conversely, we observed a negative relationship between the length of these microplastics and human environmental impact. These insights significantly contribute to the understanding of microplastic pollution in freshwater environments, highlighting its complexities beyond marine ecosystems. Our research emphasises the intricate relationships between microplastics and freshwater organisms, underscoring the need for comprehensive strategies to mitigate microplastic pollution.
Microplastics, pervasive environmental pollutants, are found across various ecosystems, including small inland water bodies. They are reported in different environmental media, yet little is known about the mutual relationships of microplastics’ properties across components of small inland water bodies. Here, having extracted and analyzed these particles from water, sediment, and amphibian larvae from 23 sites, we test within-site similarities regarding shape (morphological type), color, and chemical composition (polymer type). We also provide a brief characterization of the microplastics extracted from water and sediment regarding these parameters. We observed a statistically significant similarity of microplastics’ shapes and colors between those extracted from water and amphibian larvae. Such a similarity, though less pronounced, was also found between amphibian larvae and sediment. However, the chemical composition (polymer type) of the microplastics from water, sediment, and amphibian larvae did not exhibit any similarities beyond what would be expected by chance. The observed congruence in the colors and shapes of microplastics between amphibian larvae and their corresponding aquatic habitats underscores the profound interconnectedness among the constituents of freshwater ecosystems.
15 June 2023 in Journal of Environmental Management
Some new cases of anomalies in wild Bufotes viridis from Western Poland are presented together with a discussion of their potential causes and a comparison with similar cases from the literature. The anomalies in question are color aberrations (pre- and post-metamorphic) and developmental pathologies (pre–metamorphic). The color anomalies include an ochre patch in a juvenile, leucism and albinism in both tadpoles and juvenile individuals. Developmental pathologies described in this paper include gigantism, edema, curvature of tail, and asymmetric bodies.
Despite technological progress, glioblastoma (GBM) continues to confer dismal prognoses. Modern neuroimaging methods are assuming an ever greater role in diagnosing and monitoring brain tumors. This review shows current neuroimaging approaches and systemic therapeutic strategies for glioblastoma, with a focus on emerging and innovative treatments. Advances in multiparametric magnetic resonance imaging—MRI (diffusion, perfusion, and spectroscopy) and novel positron emission tomography (PET) tracers, complemented by radiomics and artificial intelligence (AI), now refine tumor delineation, differentiate progression from treatment effects, and may help predict treatment responses. Maximal safe resection followed by chemoradiotherapy with temozolomide remains the standard, with the greatest benefit seen in O6-methylguanine DNA methyltransferase (MGMT) promoter-methylated tumors. Bevacizumab and other targeted modalities offer mainly progression-free, not overall survival, gains. Immune checkpoint inhibitors (e.g., nivolumab) have not improved survival in unselected GBM, while early multi-antigen CAR-T (chimeric antigen receptor T-cell) strategies show preliminary bioactivity without established durability. While actionable alterations (NTRK fusions and BRAF V600E) justify selective targeted therapy trials, their definitive benefit in classical GBM is unproven. Future priorities include harmonized imaging molecular integration, AI-driven prognostic modeling, novel PET tracers, and strategies to breach or transiently open the blood–brain barrier to enhance drug delivery. Convergence of these domains may convert diagnostic precision into improved patient outcomes.